CLDX 8-K: SEC filing
Celldex Therapeutics
Filed with the SEC on · accession 0001171843-26-007174
CLDX filed a 8-K (current report) with the SEC on Nov 5, 2026. Celldex Therapeutics reported Q3 2026 financial results and provided a corporate update, highlighting best-in-disease Phase 3 results for barzolvolimab in chronic spontaneous urticaria (CSU) with a BLA submission anticipated in 2027, ongoing Phase 3 enrollment in cold urticaria and symptomatic…
Summary of the filing
Celldex Therapeutics reported Q3 2026 financial results and provided a corporate update, highlighting best-in-disease Phase 3 results for barzolvolimab in chronic spontaneous urticaria (CSU) with a BLA submission anticipated in 2027, ongoing Phase 3 enrollment in cold urticaria and symptomatic dermographism, and discontinuation of the Phase 2 prurigo nodularis study.
Key details
✦ Ask GOAX AI about this filing — what it means for CLDX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLDX?
Click hereFrequently asked questions
What did CLDX file with the SEC on Nov 5, 2026?
CLDX filed a 8-K (SEC filing). Celldex Therapeutics reported Q3 2026 financial results and provided a corporate update, highlighting best-in-disease Phase 3 results for barzolvolimab in chronic spontaneous urticaria (CSU) with a BLA submission anticipated in 2027, ongoing Phase 3 enrollment in cold urticaria and symptomatic dermographism, and discontinuation of the Phase 2 prurigo nodularis study.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other CLDX SEC filings
Get alerts when CLDX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days